These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28472200)

  • 1. Comorbidity and progression of late onset Alzheimer's disease: A systematic review.
    Haaksma ML; Vilela LR; Marengoni A; Calderón-Larrañaga A; Leoutsakos JS; Olde Rikkert MGM; Melis RJF
    PLoS One; 2017; 12(5):e0177044. PubMed ID: 28472200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
    Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
    Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of somatic and functional variables for cognitive deterioration for early-stage patients with Alzheimer's Disease: Evidence from a prospective registry on dementia.
    Kaufmann L; Gruenbaum T; Janssen R; Weiss EM; Benke T; Dal-Bianco P; Defrancesco M; Ransmayr G; Schmidt R; Stögmann E; Marksteiner J
    PLoS One; 2024; 19(8):e0307111. PubMed ID: 39141602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological screening performance and the association with activities of daily living and instrumental activities of daily living in dementia: baseline and 18- to 24-month follow-up.
    Monaci L; Morris RG
    Int J Geriatr Psychiatry; 2012 Feb; 27(2):197-204. PubMed ID: 22223145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Alzheimer's Disease Genetic Risk Loci with Cognitive Performance and Decline: A Systematic Review.
    Andrews SJ; McFall GP; Booth A; Dixon RA; Anstey KJ
    J Alzheimers Dis; 2019; 69(4):1109-1136. PubMed ID: 31156182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease.
    Aubert L; Pichierri S; Hommet C; Camus V; Berrut G; de Decker L
    J Am Geriatr Soc; 2015 Mar; 63(3):543-7. PubMed ID: 25752337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature.
    Stanley K; Walker Z
    Int Psychogeriatr; 2014 Dec; 26(12):1945-53. PubMed ID: 24989902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from São Paulo, Brazil.
    de Oliveira FF; Pivi GA; Chen ES; Smith MC; Bertolucci PH
    J Neurol Sci; 2015 Dec; 359(1-2):127-32. PubMed ID: 26671101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A path analysis of patient dependence and caregiver burden in Alzheimer's disease.
    Garre-Olmo J; Vilalta-Franch J; Calvó-Perxas L; Turró-Garriga O; Conde-Sala L; López-Pousa S
    Int Psychogeriatr; 2016 Jul; 28(7):1133-41. PubMed ID: 26926437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional ability in executive variant Alzheimer's disease and typical Alzheimer's disease.
    Back-Madruga C; Boone KB; Briere J; Cummings J; McPherson S; Fairbanks L; Thompson E
    Clin Neuropsychol; 2002 Aug; 16(3):331-40. PubMed ID: 12607146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
    Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
    Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.